Russia Defence Forum

Would you like to react to this message? Create an account in a few clicks or log in to continue.

Military Forum for Russian and Global Defence Issues


+33
UZB-76
Arrow
Backman
lancelot
Big_Gazza
Nomad5891
Kiko
lyle6
Scorpius
owais.usmani
PapaDragon
flamming_python
limb
Walther von Oldenburg
LMFS
GarryB
kvs
SeigSoloyvov
par far
Hole
calripson
PhSt
George1
Regular
miketheterrible
Project Canada
SKALA.Medica
higurashihougi
sepheronx
magnumcromagnon
AlfaT8
NationalRus
KomissarBojanchev
37 posters

    Russian Medical Development: News

    miketheterrible
    miketheterrible

    Posts : 6124
    Points : 6100
    Join date : 2016-11-06

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  miketheterrible Wed Jul 21, 2021 8:51 pm

    kvs wrote:In "freedom country" Canada we no longer have the choice of even the AstraZeneca vaccine.   It is all mRNA GMO experimentation
    with Pfizer and Moderna.   If the long term damage from these GMO concoctions is confirmed this will be one of the biggest crimes
    against humanity in history.


    Well, you and I could file a class action lawsuite if it ever comes to it.

    GarryB likes this post

    Scorpius
    Scorpius

    Posts : 335
    Points : 337
    Join date : 2020-11-06
    Age : 33

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  Scorpius Wed Aug 04, 2021 10:33 am

    according to the Russian customs, the export of vaccines from Russia (over $300 million) for the first 5 months doubled the total value for the previous 3 years. Compared to the same period in 2020, the growth was 3,180%.
    https://forbes-ru.turbopages.org/forbes.ru/s/newsroom/biznes/436571-rossiya-eksportirovala-v-32-raza-bolshe-vakcin-dlya-lyudey-v-2021-godu

    GarryB, Big_Gazza, miketheterrible and Hole like this post

    flamming_python
    flamming_python

    Posts : 4950
    Points : 5034
    Join date : 2012-01-30

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  flamming_python Thu Aug 05, 2021 7:05 am

    Scorpius wrote:according to the Russian customs, the export of vaccines from Russia (over $300 million) for the first 5 months doubled the total value for the previous 3 years. Compared to the same period in 2020, the growth was 3,180%.
    https://forbes-ru.turbopages.org/forbes.ru/s/newsroom/biznes/436571-rossiya-eksportirovala-v-32-raza-bolshe-vakcin-dlya-lyudey-v-2021-godu

    At once joyous and sad

    Sad that so much profit should have been made off a vaccine vital for humanity at the moment

    Although it doesn't specify the actual amount of profit, rather the revenue.

    GarryB likes this post

    Russian_Patriot_
    Russian_Patriot_

    Posts : 1137
    Points : 1151
    Join date : 2021-06-08
    Location : Perm, Russia

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  Russian_Patriot_ Fri Aug 20, 2021 3:44 pm

    A new center for nuclear medicine has been opened in Khimki, Moscow Region. The Institute of Nuclear Medicine includes two separate buildings: an outpatient diagnostic complex and a Radionuclide Support Complex.
    Russian Medical Development: News - Page 15 Vpsyyk10
    Russian Medical Development: News - Page 15 Ojycad10
    Russian Medical Development: News - Page 15 Sx2qtl10

    GarryB, flamming_python and Big_Gazza like this post

    GarryB
    GarryB

    Posts : 30564
    Points : 31094
    Join date : 2010-03-30
    Location : New Zealand

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  GarryB Sat Aug 21, 2021 6:31 am

    At once joyous and sad

    Sad that so much profit should have been made off a vaccine vital for humanity at the moment

    Although it doesn't specify the actual amount of profit, rather the revenue.

    I rather suspect the figures for western pharma companies would be in the tens of billions if not trillions and they would have no shame in offering 10000% price markups during pandemics.

    I rather suspect it is total revenue and that their profits were nothing like those of the west because they are dealing with countries that simply can't afford to spend a lot of money on such things.

    The companies you should worry about are the ones that demand waivers from fault or injury and refuse to give figures about price and cost.
    Kiko
    Kiko

    Posts : 791
    Points : 807
    Join date : 2020-11-11
    Age : 72
    Location : Brasilia

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  Kiko Mon Aug 23, 2021 3:27 pm

    Skvortsova spoke about the study of the drug against coronavirus "Mir-19", 23.08.2021.

    Head of FMBA Skvortsova: report on the study of the drug against coronavirus "Mir-19" will be presented in September.

    MOSCOW, 23 Aug - RIA Novosti. The second phase of clinical trials of a Russian drug for coronavirus is ending, said Veronika Skvortsova , head of the Federal Biomedical Agency.

    “About 160 patients have already received Mir-19. We plan to submit a report to the Ministry of Health sometime in September and then resolve the issue of its registration,” she said on the air of the Russia 24 channel.

    It is known about "Mir-19" that it is an etiotropic drug, in fact, an antidote against a virus. It consists of two components - small interfering RNAs, which should prevent SARS-CoV-2 from multiplying, and a carrier peptide. According to the developers, it does not affect the human genome.

    Earlier it was reported that the creation of a medicine is a technically more difficult task than the development of a vaccine: in addition to the selection of a substance, it is necessary to calculate its concentration and dose. There is a consensus in the professional community that preventive vaccinations are more effective than treatment.

    https://ria.ru/20210823/koronavirus-1746846946.html

    GarryB, flamming_python and kvs like this post

    Russian_Patriot_
    Russian_Patriot_

    Posts : 1137
    Points : 1151
    Join date : 2021-06-08
    Location : Perm, Russia

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  Russian_Patriot_ Tue Aug 24, 2021 6:52 pm

    Technodinamika to launch mobile paramedic and midwifery centers. 

    Technodinamika Holding of Rostec State Corporation has signed a bilateral cooperation agreement with Interautocenter for the production of mobile health centers-paramedic and midwifery centers-within the framework of the Army-2021 International Military-Technical Forum. NPO Splav named after A. N. Ganichev will be engaged in completing ambulances.

    Paramedic and midwifery centers (FAP) will be formed on the basis of GAZ vehicles. Mobile health centers are planned to be delivered to all regions of Russia within the framework of the national project "Healthcare".

    "Each vehicle will be equipped with all the necessary equipment for the examination and treatment of patients on the ground, as well as for vaccination. In other words, we will get a kind of "polyclinic on wheels", which will be able to serve several localities at once. Moreover, due to the high cross – country ability of the car, medical care is possible in the most inaccessible places" – Igor Nasenkov, General Director of Technodinamika Holding said. 

    "We already have experience in assembling such medical complexes. Since 2019, NPO Splav has been an aggregator and supplier of ambulances under the program of updating the ambulance fleet in the regions of Russia. The company is engaged in completing vehicles with Russian-made medical equipment" – Vladimir Kondaurov, Deputy General Director for Civil Products of JSC NPO Splav named after A. N. Ganichev said. 

    Vehicle assembly is carried out jointly with the partner company on the certified site of the enterprise. Here, cars are also equipped with medical equipment. The fleet of cars is formed on the basis of the Gazelle-Business and Gazelle-NEXT chassis, and for regions with hard – to-reach settlements-on the basis of GAZ Sobol.

    Also, within the framework of the Army-2021 military-technical forum, Splav NGO presented new medical devices-LifeStream HEPAR and LifeStream ECMO complexes, which allow resuscitating patients with sudden cardiac arrest and pulmonary insufficiency, restoring and maintaining the viability of transplants both in the donor patient's body and outside the body. There are no analogues of such equipment in Russia today.

    The work is carried out jointly with the Central Research and Development Institute of Robotics and Technical Cybernetics of St. Petersburg. The medical co-executor of the project is the First Saint Petersburg State University named after Academician I. P. Pavlov.

    One of the perfusion complexes developed as part of the project – LifeStream ECMO – is designed to maintain artificial blood circulation in the patient's body during cardiac arrest, blood oxygen saturation (oxygenation) during the development of acute respiratory failure for subsequent transportation of the patient to the hospital, intensive care unit and intensive care unit. The implementation of this project will reduce mortality from acute respiratory failure and sudden cardiac arrest.

    "The device can be successfully used for extracorporeal support of patients in critical condition with acute respiratory or heart failure caused by COVID-19. Its effectiveness has already been proven in an experiment on animals simulating sudden cardiac arrest. At the moment, the device is undergoing state registration" – Alexander Smirnov, General Director of the Ganichev Splav NGO said. 

    Another development – the LifeStream HEPAR complex is able to solve one of the main problems of transplantology-the shortage of donor organs. Perfusion devices currently available on the transplantology market provide preservation and prolongation of organ storage under low temperature conditions. This approach is justified only when working with donor organs of perfect quality. The perfusion complex "Alloy" is able to restore damaged donor organs (liver), as well as assess the functional state of the organ, transport and treatment.

    Source: 
    Russian Medical Development: News - Page 15 Img_2185
    Kiko
    Kiko

    Posts : 791
    Points : 807
    Join date : 2020-11-11
    Age : 72
    Location : Brasilia

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  Kiko Wed Sep 01, 2021 8:43 pm

    "We do not expect serious side effects": Director of the Institute of Immunology - on the drug for the treatment of coronavirus "MIR-19", by Ekaterina Kiyko for RT Rússia. 01/09/2021.

    In Russia, the second stage of clinical trials of the drug for the treatment of coronavirus "MIR-19" is coming to an end. Musa Khaitov, director of the Institute of Immunology of the Federal Medical and Biological Agency of Russia, spoke about this in an interview with RT. According to him, during the first two stages of the study, the safety of the drug was demonstrated. Experts expect that MIR-19 will be intended for patients of all ages. The immunologist added that work is now underway to create an industrial technology for the production of the drug, so that after registration it will be available to as many Russians as possible.

    What is the mechanism of action of the drug "MIR-19"? What are its main characteristics?

    "MIR-19" is a unique etiotropic antiviral drug that acts directly on the SARS-CoV-2 virus that causes COVID-19. It was created in such a way that its active component is the so-called small interfering RNAs. Therefore, the drug is called "MIR-19", this is an abbreviation ... This RNA is aimed at a certain conserved part of the genome of the SARS-CoV-2 virus, which, after interaction, undergoes certain modifications and thus is effectively removed from the infected cell.

    The main entrance gate of infection is the upper respiratory tract. The virus multiplies in the epithelium of the upper and lower respiratory tract. We need to suppress its reproduction. Therefore, inhalation was tested and it was proved that this is the most effective way of delivering the drug and so it will be able to most effectively implement its antiviral activity.

    Why have no effective drugs against coronavirus been created in the world until today?

    The fact is that the creation of a drug is a very long process. You need to understand that this takes years, and maybe decades. A little more than a year and a half has passed since the beginning of the epidemic. And accordingly, the leading scientific teams of the world began to develop drugs against SARS-CoV-2 almost a year and a half ago. Therefore, today a very large number of candidate drugs are at various stages of development all over the world.

    With the drug "MIR-19" in just over a year and a half we managed to go through this very difficult path: from the idea of ​​developing the drug itself to the second phase of clinical trials. This became possible thanks to the colossal work of our team at the Institute of Immunology, as well as our partners - the St. Petersburg Institute of Vaccines and Serums.

    Have you already published an article about the effectiveness of your drug in international peer-reviewed journals? Are you planning any other publications on the efficacy, safety of the drug and the last stage of trials?

    In April of this year, we published an article in Allergy magazine. It is by far the world's leading journal of clinical immunology. In it, for the first time in the world, we demonstrated the possibility of creating an antiviral drug against SARS-CoV-2 based on small interfering RNAs. Of course, after the completion of the second phase of clinical trials and registration of the drug, we will publish the data in a serious international scientific publication.

    Does the drug "MIR-19" have analogues?

    There are no registered analogues. The drug is absolutely unique.

    In your last interview with RT, you mentioned that the drug is absolutely safe. To date, have not been identified any side effects? Will the drug be indicated for all age groups?

    The drug has gone through a full cycle of preclinical studies, where it was demonstrated that it is safe and belongs to the class of low-toxic compounds. Based on this, we received permission from the Ministry of Health to conduct the first phase of clinical trials, where safety is checked in healthy volunteers. The safety of the drug has been confirmed.

    Today we are conducting the second phase of clinical trials, where its safety will be confirmed already in patients with coronavirus. Considering the mechanism of action of the drug and the results that we received during preclinical studies and in the first phase, we do not expect any serious side effects from it. I would very much like to hope that it will be available to both elderly patients and the smallest children.

    Will MIR-19 be used only for the treatment of COVID-19? Or will it be able to form immunity against coronavirus infection, like a vaccine?

    The fact is that MIR-19 is a drug, that is, it is not capable of forming immunity, like vaccines. It can lead to a decrease in viral load in a person who has contracted the coronavirus. Accordingly, a person recovers much faster by taking this drug.

    In September, you are going to submit documents to the Ministry of Health for registration of the drug. Do you currently have a project for the production of the first doses of the drug, how much do you plan to release?

    The second phase of clinical trials of the drug is now coming to an end. After submitting the report to the regulator, we will initiate the registration procedure. First of all, the drug will be available in hospitals, that is, those patients who need it most. Now we are very actively working on scaling up, on creating industrial technology, so that in the future the drug, of course, will be available to all segments of the population.

    Are there already requests for the use of the drug "MIR-19" from foreign countries?

    Yes, there is interest. In particular, representatives of pharmaceutical companies from Japan and South Korea contacted me with letters. It is planned to export the drug to other countries. I would like to help as many people as possible who can potentially get coronavirus.

    https://russian.rt.com/science/article/901631-lekarstvo-koronavirus-mir-19-fmba

    GarryB, kvs, Hole and Russian_Patriot_ like this post


    Sponsored content

    Russian Medical Development: News - Page 15 Empty Re: Russian Medical Development: News

    Post  Sponsored content


      Current date/time is Sat Sep 18, 2021 10:13 pm